Robert Wild
Fondatore presso Dracen Pharmaceuticals, Inc.
Profilo
Robert Wild is the founder of Dracen Pharmaceuticals, Inc. He is currently an Executive In Residence at ShangPharma Innovation, Inc. He previously worked as Senior Director & Head at OSI Pharmaceuticals, Inc. and as Chief Scientific Officer & Senior VP-Research at Ignyta, Inc. He also served as Chief Scientific Officer at Eli Lilly & Co. Dr. Wild received his undergraduate and doctorate degrees from the University of Minnesota.
Posizioni attive di Robert Wild
| Società | Posizione | Inizio |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Consulente / Consigliere | 01/03/2017 |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Fondatore | - |
Precedenti posizioni note di Robert Wild
| Società | Posizione | Fine |
|---|---|---|
| IGNYTA INC | Direttore Tecnico/Scientifico/R&S | 22/02/2016 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2010 |
| ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Robert Wild
| University of Minnesota | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 4 |
|---|---|
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
- Borsa valori
- Insiders
- Robert Wild
